High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes

Development of drug-resistant mutations has been a major problem with all currently developed Hepatitis C Virus (HCV) NS3/4A inhibitors, including the two FDA approved drugs, significantly reducing the efficacy of these inhibitors. The high incidence of drug-resistance mutations and the limited util...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun, Zhu, Tian, Patel, Kavankumar, Zhang, Yan-Yan, Truong, Lena, Hevener, Kirk E., Gatuz, Joseph L., Subramanya, Gitanjali, Jeong, Hyun-Young, Uprichard, Susan L., Johnson, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793977/
https://www.ncbi.nlm.nih.gov/pubmed/24130685
http://dx.doi.org/10.1371/journal.pone.0075144

Ejemplares similares

Ejemplares similares